HTTP 200 verified twice
Finding your next stop…
Loading the latest directory information.
Loading the latest directory information.
1Day Sooner is a US-registered 501(c)3 advocacy nonprofit founded in March 2020 that supports healthy volunteers in high-impact medical studies, particularly human challenge trials. Its Cooperative Participant Organization embeds staff scientists into study teams worldwide, with a current focus on Europe, North America, and Africa.
Start with the essentials: 1Day Sooner’s public mission, organization type, programs and the recorded sources behind this profile.
1Day Sooner Inc., a Delaware non-profit corporation
Read-only public captures of 1Day Sooner’s homepage. Screenshots are dated, never live embeds, and open full-screen.
Nonprofit profiles focus on the public information that helps readers understand an organization's role: mission, governance, funding context, programs and reporting.
Short answers to the questions buyers and builders commonly ask about 1Day Sooner. Each answer cites the shared ledger below, where every source is listed once.
Healthy volunteers willing to participate in human challenge trials and early-phase clinic · Researchers and investigators running early-phase, high-impact clinical trials.
Our Cooperative Participant Organization (CPO) embeds 1Day Sooner staff scientists directly into study teams worldwide
CPO initial institutional collaborators include Leiden University, Malawi Liverpool Wellco
Researchers at Leiden University, Malawi Liverpool Wellcome Research Programme, University of Oxford, and others are the first collaborators of 1Day Sooner's CPO program.
Contact email privacy@1daysooner.org and phone 774-481-1235 for privacy inquiries.
Phone: 774-481-1235 Email: privacy@1daysooner.org
Leads campaigns in science, policy, and ethics to stop the world's most harmful infectious
1Day Sooner leads campaigns in science, policy, and ethics to stop the world's most harmful infectious diseases.
Cooperative Participant Organization (CPO), launched September 15, 2025, embeds 1Day Soone · Volunteer recruitment and advocacy for human challenge trials (controlled human infection
We've launched our Cooperative Participant Organization (CPO), a first-of-its-kind independent collaborative organization that supports early-phase, high-impact clinical trials
CPO collaborates with institutions globally, with a current focus on Europe, North America
The CPO collaborates with institutions globally, with a current focus on Europe, North America, and Africa.
This profile connects the jobs 1Day Sooner is described as handling with its delivery model, access options and the subjects used to match it to related products in this directory.
Each fact points to a recorded source, making it easy to distinguish verified product information from claims that need checking.
HTTP 200 verified twice
1Day Home - 1Day Sooner
1Day Sooner Inc. is a Delaware non-profit corporation · Leads campaigns in science, policy, and ethics · Mission to stop the world's most harmful infectious diseases
1Day Sooner Inc., a Delaware non-profit corporation
Leads campaigns in science, policy, and ethics to stop the world's most harmful infectious diseases and to honor research participants through maximally efficient and equitable use of research results.
Cooperative Participant Organization (CPO), launched September 15, 2025, embeds 1Day Sooner staff scientists directly into early-phase clinical trial study teams worldwide.
Volunteer recruitment and advocacy for human challenge trials (controlled human infection studies), including shigellosis, hepatitis C, Group A Strep, tuberculosis, and pneumococcal vaccine trials.
CPO collaborates with institutions globally, with a current focus on Europe, North America, and Africa.
CPO initial institutional collaborators include Leiden University, Malawi Liverpool Wellcome Research Programme, and University of Oxford.
1Day Sooner
Healthy volunteers willing to participate in human challenge trials and early-phase clinical trials.
Researchers and investigators running early-phase, high-impact clinical trials.
A concise view of the jobs, capabilities and integrations described in the recorded product sources.
Documented product formats, platforms and official distribution destinations. Availability can vary by region and plan.
A concise history of launches, product changes and company milestones. Events appear only when a dated source supports what changed.
Showing the newest updates and meaningful milestones. Open an entry for its summary and source.
At a first-ever UN High-level Side Event, global public health leaders signed a pledge declaring healthy indoor air a fundamental human right.
View source [3]1Day Sooner launched a cooperative participant organization to aid clinical trial research, with three world-renowned institutions joining.
View source [3]A 1Day Africa analysis concluded the R21 malaria vaccine is a cost-effective intervention compared to common malaria prevention measures.
View source [3]An open letter signed by 121 global experts called for hepatitis C controlled human infection studies to accelerate vaccine development.
View source [3]1Day Sooner announced the release of results from the COVID-19 human challenge study, marking a major milestone in pandemic research.
View source [3]Facts, answers, structured details, milestones and primary resource links cite this shared ledger. Each external page appears once; release tags from the same GitHub project are grouped under one release history.
These tools share a workflow, capability or audience with 1Day Sooner. They may complement it rather than replace it, and are not presented as integrations or endorsements.
Contact email privacy@1daysooner.org and phone 774-481-1235 for privacy inquiries.
Maintains a presence on Facebook, Instagram, Twitter (X), and YouTube.
Mission to honor research participants through equitable use of results · Leads campaigns in science, policy, and ethics against harmful infectious diseases · CPO embeds staff scientists into study teams worldwide
1Day Sooner envisions a world where the risks taken by research participants are honored through maximally efficient and equitable use of research results.
Leads campaigns in science, policy, and ethics to stop the world's most harmful infectious diseases.
Cooperative Participant Organization (CPO) embeds 1Day Sooner staff scientists directly into study teams worldwide, especially in controlled human infection studies.
Cooperative Participant Organization (CPO) launched September 15, 2025.
Initial CPO collaborators include researchers at Leiden University, Malawi Liverpool Wellcome Research Programme, and University of Oxford.
Josh Morrison is the co-founder and President of 1Day Sooner; he holds a JD from Harvard Law School.
Operates additional programs including Pandemic Preparedness, Pandemic Insurance Fund, Challenge Model Development Group, and Target Product Profile Design.
1Day Sooner leads campaigns in science, policy, and ethics to stop the world's most harmfu · Envisions a world where risks taken by research participants are honored through efficient · Launched the Cooperative Participant Organization (CPO) on September 15, 2025, supporting
We envision a world where the risks taken by research participants are honored through maximally efficient and equitable use of research results
1Day Sooner leads campaigns in science, policy, and ethics to stop the world's most harmful infectious diseases
Cooperative Participant Organization (CPO), launched September 15, 2025 — a first-of-its-kind independent collaborative organization that supports early-phase, high-impact clinical trials driven by the experience of and involving healthy pa
The CPO collaborates with institutions globally, with a current focus on Europe, North America, and Africa
First collaborators of 1Day Sooner's CPO program include Leiden University, Malawi Liverpool Wellcome Research Programme, and University of Oxford
1Day Africa program focused on global vaccine equity and the integration of developing countries into modern medical research
Involvement in scientific, regulatory, and ethical discussions about clinical research and the products that come from it, including vaccines, treatments, and new knowledge about infectious diseases
Human challenge studies research for shigellosis, examined for vaccine development and ethical considerations surrounding intentional infection of healthy volunteers
Hepatitis C controlled human infection model studies and related vaccine development advocacy
Josh Morrison is co-founder and President of 1Day Sooner; also founded Waitlist Zero and the Rikers Debate Project; holds a JD from Harvard Law School
Board of Directors includes Josh Morrison, Julia Murdza, Jake Eberts, Joel Lawson, Stanley Plotkin, Madeleine Thompson, and Dan Wikler; Julia Murdza serves as COO
Founded March 2020 · US-registered 501(c)3 nonprofit · Delaware non-profit corporation (1Day Sooner Inc.)
Advocacy group (not a medical research organization)
Delaware non-profit corporation (1Day Sooner Inc.)
Advocates for human challenge trials and other clinical research involving healthy volunteers, including vaccines, treatments, and new infectious disease knowledge.
Healthy volunteers who participate in clinical and challenge trials, including those in isolation units for respiratory disease challenge studies.
Cooperative Participant Organization (CPO), launched September 15, 2025; a first-of-its-kind independent collaborative organization that embeds 1Day Sooner staff scientists into study teams and supports early-phase, high-impact clinical tri
